The purpose of this study is to investigate advanced malignancies. Participants will receive an investigational medication to determine the best treatment dose and to study its safety and effectiveness.
This study evaluates the investigational medication's safety and effectiveness in treating advanced malignancies. Researchers will observe how well participants respond to the treatment and monitor any side effects.
- Who can participate: Participants must be 18 years or older with advanced or metastatic malignancies and have tumors measurable by standard assessments.
- Study details: Participants will take the investigational medication orally twice a day.